HUMAN ALBUMIN 200gl BAXTER Singapore - English - HSA (Health Sciences Authority)

human albumin 200gl baxter

takeda pharmaceuticals (asia pacific) pte. ltd. - human albumin - solution, sterile - 200 mg/ml - human albumin 200 mg/ml

HUMAN ALBUMIN GRIFOLS INJECTION 5% Singapore - English - HSA (Health Sciences Authority)

human albumin grifols injection 5%

grifols asia pacific pte. ltd. - albumin (human serum) (venous) - injection - 5.00% - albumin (human serum) (venous) 5%

HUMAN ALBUMIN GRIFOLS 20% Singapore - English - HSA (Health Sciences Authority)

human albumin grifols 20%

grifols asia pacific pte. ltd. - albumin (human serum) (venous) - infusion, solution - 0.2 g/ml - albumin (human serum) (venous) 0.2 g/ml

OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES- human albumin microspheres and perflutren injection, solution United States - English - NLM (National Library of Medicine)

optison perflutren protein-type a microspheres- human albumin microspheres and perflutren injection, solution

ge healthcare inc. - human albumin microspheres (unii: t8c6w1n6nw) (human albumin microspheres - unii:t8c6w1n6nw), perflutren (unii: ck0n3wh0sr) (perflutren - unii:ck0n3wh0sr) - human albumin microspheres 10 mg in 1 ml - optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. do not administer optison to patients with known or suspected hypersensitivity to perflutren or albumin [see warnings and precautions (5.5)] . risk summary there are no data with optison use in pregnant women to inform any drug-associated risks. no adverse developmental outcomes were observed in animal reproduction studies with intravenous administration of optison to pregnant rats and rabbits during organogenesis at doses up to at least 5 and 10 times the recommended human dose based on body surface area (see data ). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. data animal data optison was administered intravenously to rats at doses of 0.25, 5 and 10 ml/kg/day (approximately 0.2, 5 and 10 times the recommended maximum human dose of 8.7 ml, respectively, based on body surface area) and to rabbits at 0.25, 2.5 and 5 ml/kg/day (approximately 0.5, 5 and 10 times the recommended maximum human dose, respectively, based on body surface area) during organogenesis. no significant findings attributable solely to a direct effect on the fetus were detected in the studies. there are no data on the presence of perflutren protein-type a microspheres in human milk, the effects on the breastfed infant, or the effects on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for optison and any potential adverse effects on the breastfed infant from optison or from the underlying maternal condition. safety and effectiveness in pediatric patients have not been established. of the total number of subjects in a clinical study of optison, 35% were 65 and over, while 14% were 75 and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Human Albumin Baxalta 50 g/l inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin baxalta 50 g/l inf. sol. i.v. vial

baxalta innovations gmbh - albumin human 50 g/l - solution for infusion - 50 g/l - albumin human 50 mg/ml - albumin

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Human Albumin Solution for Infusion 20% Behring Singapore - English - HSA (Health Sciences Authority)

human albumin solution for infusion 20% behring

csl behring pte. ltd. - human albumin - infusion, solution - 200g/l - human albumin 200g/l

ALBUMIN (HUMAN) 5% SOLUTION, USP Canada - English - Health Canada

albumin (human) 5% solution, usp

grifols therapeutics llc - albumin (human) - solution - 5% - albumin (human) 5% - blood derivatives

ALBUMIN (HUMAN) 25% SOLUTION USP Canada - English - Health Canada

albumin (human) 25% solution usp

grifols therapeutics llc - albumin (human) - solution - 25% - albumin (human) 25% - blood derivatives